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Abstract
Intraductal papillary mucinous neoplasms are classified into gastric, intestinal, pancreatobiliary, 
and oncocytic subtypes where morphology portends disease prognosis. The study aim was to 
demonstrate EUS-guided needle-based confocal laser endomicroscopy imaging features of 
intraductal papillary mucinous neoplasm subtypes. Four subjects, each with a specific intraductal 
papillary mucinous neoplasm subtype were enrolled. An EUS-guided needle-based confocal laser 
endomicroscopy miniprobe was utilized for image acquisition. The mean cyst size from the 4 
subjects (2 females; mean age = 65.3±12 years) was 36.8±12 mm. All lesions demonstrated mural 
nodules and focal dilation of the main pancreatic duct. EUS-nCLE demonstrated characteristic 
finger-like papillae with inner vascular core for all subtypes. The image patterns of the papillae for 
the gastric, intestinal, and pancreatobiliary subtypes were similar. However, the papillae in the 
oncocytic subtype were thick and demonstrated a fine scale-like or honeycomb pattern with 
intraepithelial lumina correlating with histopathology. There was significant overlap in the needle-
based confocal laser endomicroscopy findings for the different intraductal papillary mucinous 
neoplasm subtypes; however, the oncocytic subtype demonstrated distinct patterns. These findings 
need to be replicated in larger multicenter studies.
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INTRODUCTION
Pancreatic cancer is a leading cause of cancer-related mortality in the United States. There 
has been a greater emphasis on early detection of pancreatic lesions in individuals at high-
risk for pancreatic cancer. Intraductal papillary mucinous neoplasms (IPMNs) are cystic 
precursor lesions of pancreatic cancer. IPMNs are classified by location of involvement into 
main duct and branch duct types, and by histology into gastric, intestinal, pancreatobiliary, 
and oncocytic subtypes [1]. Main duct involvement portends a worse prognosis compared to 
the branch duct type [2]. IPMN morphology has been shown to be an independent predictor 
of patient prognosis where oncocytic and pancreatobiliary subtypes are associated with 
adverse malignant potential and clinical outcomes [3].
While current guidelines recommend surgical resection of IPMNs with high-risk features, 
they do not include pathological subtype in risk stratification. Pre-operative identification of 
IPMN subtype can potentially influence long-term management and outcomes. Pancreatic 
juice cytology with mucin (MUC) staining may be useful in the preoperative diagnosis of 
IPMN subtypes [4]. However, at present, there is a lack of data on pre-operative 
identification of IPMN subtypes and presence of high-grade dysplasia.
Confocal laser endomicroscopy (CLE) is a laser-guided microscopic imaging system that 
allows for real time histopathology of tissue structures via fluorescence contrast [5]. While 
differentiating mucinous from non-mucinous cystic lesions is clinically challenging, CLE 
has been previously successful in diagnosing IPMNs [5]. The objective of this study was to 
demonstrate EUSnCLE imaging features of the four subtypes of IPMNs and to correlate 
their features to histopathology using representative cases in a pre-surgical setting.
Patients and Methods
Patients (n=3) with the gastric, intestinal, and pancreatobiliary IPMN subtypes were among 
participants enrolled in a prospective study (INDEX trial; ClinicalTrials.gov NCT02516488) 
at The Ohio State University Medical Center. One patient with the oncocytic subtype was 
managed at the Indiana University Hospital. This case series is a retrospective analysis of the 
four patients highlighted previously, each with one of the four IPMN subtypes, including 
gastric, intestinal, pancreatobiliary, and oncocytic subtypes. Prior approval from the 
respective Institution Review Boards was obtained.
Data Collection
Patient history, demographics, comorbidities, laboratory, and imaging findings were 
collected using a standardized data collection form. EUS was performed to determine the 
size of the cyst, location, compartments, presence or absence of main pancreatic duct 
dilation, septation, internal debris, mural nodules, and wall thickness. Fine needle aspiration 
(FNA) was performed after nCLE to obtain cyst fluid for CEA and amylase levels, and 
cytology.
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EUS-nCLE Technique
All EUS examinations were completed using the standard linear echoendoscope (Olympus 
America, Center Valley, PA, USA). Fluorescein (5 mL of 10% fluorescein sodium) was 
injected intravenously (IV) 2–3 minutes prior to CLE imaging. The AQ-Flex nCLE 
miniprobe (Cellvizio, Mauna Kea Technologies, Paris, France) was preloaded into a 19-
gauge Flex (Nitinol) needle (Boston Scientific, Natick, MA, USA) and secured in place by a 
locking device. The preloaded needle was inserted into the echoendoscope and under EUS 
guidance, advanced into the lesion of interest via transduodenal or transgastric route. The 
nCLE probe was then advanced beyond the tip of the FNA needle until it made a soft contact 
with pancreatic cyst epithelium of a wall or inner mural nodule. Intracystic endomicroscopic 
images were obtained with permitted angulation of the 19-gauge needle. After image 
acquisition was complete (generally after 6–8 minutes), the locking device was subsequently 
released and the AQ-Flex miniprobe was removed from the FNA needle. A syringe with 
negative suction was attached to the proximal end of the FNA needle and cyst fluid was 
collected. A dose of IV fluoroquinolone was administered on the day of the procedure and 
oral quinolone was continued for three days afterwards.
Histopathology
All IPMN lesions underwent surgical resection and standard pathology processing for 
identification of specific subtypes.
Data Analysis
A specially designed software program (Cellvizio Viewer; Mauna Kea Technologies, Paris, 
France; free for download) was used to review all nCLE images and videos. After review of 
surgical histopathology, a post-hoc frame-by-frame review of all nCLE videos was 
performed.
RESULTS
Study Cohort
A total of 4 subjects (2 male, 2 female) with a mean age of 65.3±12 years underwent EUS-
nCLE with subsequent surgical resection and histopathology analysis. Clinical, imaging, 
EUS, and pathological features are listed in Table 1. The mean size of these lesions was 
37±12 mm. All lesions demonstrated mural nodules and focal dilation of the main pancreatic 
duct indicating a mixed duct IPMN. Three patients presented with related abdominal pain as 
the presenting symptom that prompted cross sectional imaging with discovery of the 
pancreatic cystic lesions (PCLs).
Histopathology
The histopathology associated with each IPMN subtype is illustrated in Figure 1. 
Pancreatobiliary IPMN consisted of cells resembling cholangiobiliary neoplasms and 
demonstrated short, complex papillae with occasional cribriform structures. Gastric IPMN 
demonstrated thick finger-like papillae and resembled gastric foveolar epithelium with 
pyloric-type glands in the periphery. Intestinal IPMN resembled intestinal villous adenomas 
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with tall columnar epithelial cells, pseudostratification, and presence of goblet cells. 
Oncocytic IPMN revealed thick complex papillae with intraepithelial lumina and neoplastic 
cells with abundant, intensely eosinophilic cytoplasm.
EUS-guided nCLE
All IPMN lesions had characteristic epithelial bands with finger-like projections or papillae 
(Figure 1). The papillae appeared as dark bands, which represent the outer epithelium, 
surrounding a central lighter area, which represents the inner vascular core. The papillae 
were easily and consistently observed in all 4 cases. These papillae are observed in various 
configurations based on the location of the nCLE probe. While characteristic finger-like 
appearance is most suggestive, other variations include ‘alternating light and dark bands’ 
and a ‘target’ or ‘dough-nut’ configuration with outer epithelium and inner vascular core. 
Due to the extensive vascularity, the background appeared generally bright in all IPMNs 
with high uptake of IV fluorescein.
An important distinction that was observed for the oncocytic IPMN subtype is that the 
papillae demonstrated multiple fine clefts and scale-like appearance within the papillae 
(Figure 2). This appearance is secondary to their characteristic intraepithelial lumina, which 
was also observed in histopathology (Figure 2). The image patterns of the papillae for the 
gastric, intestinal, and pancreatobiliary subtypes were generally similar without delineating 
distinctive features.
DISCUSSION
In this case series, we demonstrate that EUS-nCLE has the ability to provide diagnostic 
imaging of IPMNs and potentially identify the oncocytic subtype in a preoperative setting. 
While the pathological features of other subtypes were not easily distinguishable on EUS-
nCLE, the oncocytic subtype demonstrated fine fissures and a scale-like appearance of the 
papillae corresponding to the pathologically documented intraepithelial lumina [6]. These 
distinctive features may be relatively specific for oncocytic IPMN that often give the 
proliferation an arborizing cribriform architecture when observed either longitudinally or in 
cross-section. Since the nCLE (AQ-Flex miniprobe) has a maximum lateral resolution of 3.5 
µm, these relatively larger epithelial characteristics can be observed. To our knowledge, this 
is the first study describing pre-surgical EUS-nCLE findings in definitively diagnosed IPMN 
subtypes.
The defining feature of IPMN lesions on nCLE imaging is the finger-like papillae, which 
consists of an outer epithelium and an inner vascular core, consistent with prior studies [5]. 
Although all IPMN subtypes have similar morphologic features, considerable variability 
exists between pathologists in diagnosing them. In one study, five gastrointestinal 
pathologists were able to achieve a consensus diagnosis for only 58% of cases [7]. This 
could imply similar variabilities in EUS-nCLE guided differentiation of IPMN subtypes. For 
conclusive differentiation, pathologists utilize immunohistochemistry of mucin core proteins 
(MUCs) since each IPMN subtype has a unique immunoprofile [7, 8]. Since nCLE can only 
identify the distinguishing characteristics of the oncocytic subtype, perhaps future focus 
should be more on detecting high-grade dysplasia than categorizing the four subtypes.
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In addition to morphologic differences, the oncocytic subtype is also genetically distinct 
from the other IPMN subtypes, as it does not typically harbor the traditional IPMN 
mutations such as KRAS [9]. The characteristic histopathologic pattern seen with the 
oncocytic subtype consists of arborizing papillae with cells exhibiting prominent nucleoli 
and intraepithelial lumina [9]. It is important to note that oncocytic IPMN typically occurs in 
the main pancreatic duct and can have recurrences several years after resection [10]. 
Additionally, both oncocytic and pancreatobiliary IPMN subtypes are associated with more 
frequent high-grade dysplasia, which predisposes them to develop into invasive carcinomas 
[8].
Additional studies are necessary to confirm these findings before they become defining 
features of IPMN lesions given the small study sample size of four cases. Additionally, 
nCLE image acquisition is limited by the angulation of the 19-gauge needle and there may 
have been areas of the PCL that may not have been imaged. Lastly, intraobserver variability 
may exist in interpreting and analyzing the nCLE image patterns.
The addition of nCLE-based epithelial features to the standard evaluation of PCLs may 
improve the pre-operative diagnostic evaluation of PCLs. Overall, there was significant 
overlap in the EUS-nCLE imaging for the different IPMN subtypes; however, the oncocytic 
subtype demonstrated distinct nCLE patterns. The small sample size of the case series limits 
the generalizability of these patterns. Nevertheless, these findings suggest that additional 
investigations are necessary including exploring the potential of EUS-nCLE for detecting 
high-grade dysplasia and risk stratification of IPMN lesions.
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Abbrevations
nCLE needle-based confocal laser endomicroscopy
IPMN intraductal papillary mucinous neoplasm
PDAC pancreatic ductal adenocarcinoma
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Figure 1. 
A comparison of the needle-based confocal laser endomicroscopy and histopathology 
findings for pancreatobiliary, gastric, intestinal, and oncocytic subtypes of intraductal 
papillary mucinous neoplasms: the oncocytic IPMN subtype demonstrates papillae with 
multiple fine clefts and scale-like appearance due to characteristic intraepithelial lumina.
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Figure 2. 
Oncocytic subtype intraductal papillary mucinous neoplasm demonstrating intraepithelial 
lumina (yellow arrows). The entire papilla of interest is bounded by the green arrows. There 
is good correlation between needle-based confocal laser endomicroscopy and histopathology 
findings.
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Table 1
Demographics, clinical features, EUS and FNA characteristics and findings, and final diagnosis of patients 
with intraductal papillary mucinous neoplasms (IPMNs).
1 2 3 4
Gender Female Male Female Male
Age (years) 67 71 75 48
History of pancreatitis No No Yes No
Diabetes Mellitus, type 2 Yes Yes No No
Abdominal symptoms Symptomatic Incidental Symptomatic Symptomatic
EUS features
Size (mm) 21×18 40×25 36×14 50×38
Location Head Head Body Body/neck
MPD communication or 
dilation
Yes Yes Yes Yes
Compartments Multiple Multiple One Multiple
Septation Thin Thin Thin Thin
Internal debris No No No Yes
Wall thickness No Variable No Yes
Mural nodule 9 mm hypoechoic 
nodule
14 mm solid (mural) 
nodule
Calcified mural nodule Hyperechoic, irregular 
mural nodule (22×18 
mm)
FNA
Route Transduodenal Transduodenal Transgastric Transgastric
Quantity (FNA; mL) 3 1 4 5
Fluid characteristics Clear, viscous, visible 
mucous material
Viscous Clear, serous, slightly viscous Thin
Cyst CEA (ng/dL) 188 Fluid too thick to 
measure
148.3 53
Cyst amylase (IU/dL) >10,000 Fluid too thick to 
measure
7,583 Not performed
Cytology Mucin and clusters of 
epithelial cells with 
moderate atypia
Scant mucin Scant mucin Numerous epithelial cells 
with abundant, granular 
and vacuolated 
cytoplasm
Final diagnosis Gastric type IPMN Intestinal type IPMN Pancreatobiliary type IPMN Oncoytic type IPMN
CEA carcinoembryonic antigen; MPD main pancreatic duct
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